Impact of Job Related Activities on Female Physiotherapist and Dentist During Internship Year

October 9, 2023 updated by: Hend Reda Sakr, Badr University
Response of hand grip, pinch grip and body composition to type of effort between female physiotherapist and female dentist at internship year.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Fifty physiotherapist and fifty dentist females will be selected from faculty of physical therapy and faculty of dentistry at Badr University in Cairo BUC, both at internship year, and will be assigned into two groups. Group A consists of fifty physiotherapist females will participate in this group and will be assessed at the beginning of the study and after 6 months of clinical work. Group B consists of fifty dentist females will participate in this group and will be assessed at the beginning of the study and after 6 months of clinical work. Digital hand dynamometer will be used to assess hand grip strength and InBody device will be used to assess changes in body composition at the beginning and the end of the study.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Egypt
    • Badr City
      • New Cairo, Badr City, Egypt, 11829
        • Recruiting
        • Badr University in Cairo
        • Contact:
        • Principal Investigator:
          • Hend R Sakr, PhD
    • New Cairo
      • Cairo, New Cairo, Egypt, 11829
        • Recruiting
        • Faculty of Physical Therapy, Badr University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Fifty physiotherapist and fifty dentist females will be selected from faculty of physical therapy and faculty of dentistry at Badr University in Cairo BUC

Description

Inclusion Criteria:

  1. Fifty physiotherapist females and fifty dentist females at internship year.
  2. Their age will be ranged from 21 to 24 years old.
  3. They are medically stable and consented to participate in the study.
  4. They are able to follow instructions.

Exclusion Criteria:

  1. History of any pathological disease-causing disorder in metabolism such as thyroid gland disorder.
  2. History of muscular or neurological disorder.
  3. Using any hormonal treatment.
  4. Following any diet modification method.
  5. Severe emotional stress.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Group A
Fifty physiotherapist females will participate in this group and will be assessed at the beginning of the study and after 6 months of clinical work.
Other: job related activities
Different types of effort offered by female physiotherapist and female dentist during clinical practicing with patients in internship year
Group B
Fifty dentist females will participate in this group and will be assessed at the beginning of the study and after 6 months of clinical work.
Other: job related activities
Different types of effort offered by female physiotherapist and female dentist during clinical practicing with patients in internship year

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Fist Grip
Time Frame: We measure fist grip at 1st time at the beginning of work as interns in clinic then we re-measure fist grip again to assess its progression after 6 months of work..
Maximum grip value using hand held dynamometer
We measure fist grip at 1st time at the beginning of work as interns in clinic then we re-measure fist grip again to assess its progression after 6 months of work..
Lateral Pinch (key pinch)
Time Frame: We measure lateral pinch at 1st time at the beginning of work as interns in clinic then we re-measure lateral pinch again to assess its progression after 6 months of work.
using Jamar pinch guage
We measure lateral pinch at 1st time at the beginning of work as interns in clinic then we re-measure lateral pinch again to assess its progression after 6 months of work.
Palmer pinch (chunk pinch)
Time Frame: We measure lateral pinch at 1st time at the beginning of work as interns in clinic then we re-measure lateral pinch again to assess its progression after 6 months of work..
using Jamar pinch guage
We measure lateral pinch at 1st time at the beginning of work as interns in clinic then we re-measure lateral pinch again to assess its progression after 6 months of work..
Pulp to pulp
Time Frame: We measure pulp to pulp grip at 1st time at the beginning of work as interns in clinic then we re-measure pulp to pulp grip again to assess its progression after 6 months of work..
using Jamar pinch guage
We measure pulp to pulp grip at 1st time at the beginning of work as interns in clinic then we re-measure pulp to pulp grip again to assess its progression after 6 months of work..
Tip to tip
Time Frame: We measure tip to tip grip at 1st time at the beginning of work as interns in clinic then we re-measure tip to tip grip again to assess its progression after 6 months of work..
using Jamar pinch guage
We measure tip to tip grip at 1st time at the beginning of work as interns in clinic then we re-measure tip to tip grip again to assess its progression after 6 months of work..
Body mass index
Time Frame: We measure obesity index at 1st time at the beginning of work as interns in clinic then we re-measure obesity index again to assess its progression after 6 months of work..
Using INBODY device
We measure obesity index at 1st time at the beginning of work as interns in clinic then we re-measure obesity index again to assess its progression after 6 months of work..
Percent of body fat in kg
Time Frame: We measure percent of body fat at 1st time at the beginning of work as interns in clinic then we re-measure percent of body fat again to assess its progression after 6 months of work..
Using INBODY device
We measure percent of body fat at 1st time at the beginning of work as interns in clinic then we re-measure percent of body fat again to assess its progression after 6 months of work..
Lean muscle mass in kg
Time Frame: We measure percent of muscle mass at 1st time at the beginning of work as interns in clinic then we re-measure percent of muscle mass again to assess its progression after 6 months of work..
Using INBODY device
We measure percent of muscle mass at 1st time at the beginning of work as interns in clinic then we re-measure percent of muscle mass again to assess its progression after 6 months of work..

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Badr University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Hend R Sakr, Lecturer of Physical Therapy for Women's Health, Badr University in Cairo BUC

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 18, 2022

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 30, 2023

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
December 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 16, 2022

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 9, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
October 11, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
October 11, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
October 9, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
October 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Hend4

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings